You know that the best training programs are guided ones, with samples and workflows similar to those your new staff members will encounter on a day-to-day basis.
Are your remnant patient samples up to the task?
Lab directors often use existing patient sample remnants to train new staff members, but these come with three significant limitations:
With your lab expanding quickly, you can’t afford to delay new member training several days, repeating a process because a pre-existing remnant sample has degraded or become otherwise unusable. You need materials with known stability, whether it’s purified nucleic acid after multiple freeze-thaw cycles or a plasma sample.
You can address all three limitations of using remnant samples by using a commercial source of reference materials.
Commercial reference materials:
Precise quantitation by custom allele-specific digital PCR enhances training and performance measurements. Combined with stability that does not change over time, these materials can bring your newest contributors online quickly.
New algorithms for analysis of insertion-deletion mutations for cancer, or for greater sensitivity in calculating Z-scores for aneuploidy measurements, are published or updated frequently, or may change parameters to improve performance. Having these materials for training is invaluable for keeping your laboratory team up to date.
Testing your laboratory’s proficiency periodically goes beyond the wet-laboratory work. By choosing materials with difficult-to-detect mutations or abnormalities near the limit of detection (LOD), you can generate datasets for training or evaluation of new bioinformatics tools or parameters.
With FFPE tissue, plasma, and purified nucleic acid formats, you can train according to your laboratory’s standard operating procedures (SOPs) with well-characterized and stable materials. Bring your newest laboratory members online quickly by avoiding the inherent limitations of remnant patient samples.
Whether as synthetic plasma for NIPT or ctDNA tests, FFPE sections for different solid tumor NGS-based assays, or biosynthetic targets as purified DNA blends of mutations, SeraCare has what you need.
Contact us today for more information.